Drugs / CVI-HBV-001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02692170 | Dec 2012 → May 2015 | — | CHA Vaccine Institute Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CVI-HBV-001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02692170 ↗ |
| Modality | Vaccine | “third generation Hepatitis B vaccine” NCT02692170 ↗ |
| Route | Intramuscular | “Intramuscular injection at 0, 1, 6th month” NCT02692170 ↗ |